NCT06147908View on ClinicalTrials.gov

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

October 26, 2022

Study Completion Date

November 17, 2022

Conditions
Apetite Stimulants
Interventions
DRUG

DW5221

megestrol acetate

DRUG

DW5221-R

megestrol acetate

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY